We are at the cusp of a new era of cancer care.
Thirty years ago, the thought of a world without cancer was nothing more than a dream. But today, significant advances in science and technology are converging to bring us ever closer in the coming years and decades to long-promised cures for various cancers.
At Pfizer, we’ve shown how we can move with urgency to deliver breakthroughs that change patients’ lives. And now, we’re making significant investments to tackle cancer – one of the biggest health challenges of our lifetime. With the addition of Seagen, a world-leader in antibody-drug conjugates (ADCs), we will be at the forefront of cancer care. Together, we will bring new hope to patients everywhere.
With one of the largest investments in Pfizer’s history, we are going all in on cancer with the goal of delivering breakthroughs that drastically improve the lives of people with cancer. With Seagen’s proprietary, world-leading Antibody-Drug Conjugate (ADC) technology, together with the scale and strength of Pfizer's capabilities and expertise, we are poised to change the cancer treatment paradigm.
This a great day for Pfizer, and, more importantly, for people living with cancer, as we bring together the game-changing science and top talent of Seagen and Pfizer to form a leading Oncology organization.
Our Oncology Treatments
|
brentuximab vedotin
|
exemestane
|
inotuzumab ozogamicin
|
bosutinib
|
encorafenib
|
(irinotecan hydrochloride) injection
|
glasdegib
|
(epirubicin hydrochloride) injection
|
elranatamab-bcmm
|
(estramustine phosphate sodium) capsules
|
palbociclib
|
(idarubicin hydrochloride) injection
|
axitinib
|
lorlatinib
|
binimetinib
|
gemtuzumab ozogamicin
|
filgrastim-aafi
|
pegfilgrastim-apgf
|
enfortumab vedotin-ejfv
|
epoetin alfa-epbx
|
rituximab-pvvr
|
sunitinib malate
|
talazoparib
|
temsirolimus
|
tisotumab vedotin-tftv
|
trastuzumab-qyyp
|
tucatinib
|
dacomitinib
|
crizotinib
|
bevacizumab-bvzr
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.